Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Phase separation of a PKA regulatory subunit controls cAMP compartmentation and oncogenic signaling
By using FDA-approved medications alongside structured follow-up, the program gives patients reliable tools that work within their biology rather than against it
Team proudP Jul 22, 2025 8 min read Updated: Sep 2, 2025 A Closer Look at GLP-1 Medications in Recent Research There is growing interest in how GLP-1 medications, which were originally developed for diabetes and obesity, might relate to prostate cancer
"These are meant to be a long-term drug that's titrated slowly and appropriately and monitored effectively so that you are doing the best by the patient and setting them up for success for when you eventually do maybe want to take them off of it or titrate them down." While the lucrative obesity drug market is poised to only keep growing, many digital health companies see opportunities to address chronic conditions and support patients' long-term health
US$ 24.80
US$ 28.37
US$ 24.62
US$ 29.79
US$ 25.96
US$ 26.26
